Q&A

fabry disease
fabry disease
01/25/2023
Cassiano Augusto, MD, answers our questions about his team’s recent narrative review examining Fabry disease nephropathy.
01/25/2023
health care trends
health care trends
01/14/2023
In a recent study, researchers examined how chronic kidney disease care differed among patients of different races and ethnicities. Lead study author Chi Chu, MD, MAS, answered our questions on his team’s...
01/14/2023
inflammatory bowel disease
inflammatory bowel disease
12/30/2022
Jean-Frederic Colombel, MD, from Mount Sinai, answers our questions about how the management of inflammatory bowel disease has evolved over time.
12/30/2022
medication accesss
medication accesss
12/09/2022
In this Q&A, Monica Gandhi, MD, MPH, discusses interventions to address the health care disparities that exist along the care continuum for certain patient populations who are at-risk for HIV...
12/09/2022
Conference Coverage
Jessica Rodrigues
Conference Coverage
12/07/2022
12/07/2022
hearing loss
hearing loss
11/28/2022
In this Q and A, Rebecca Sherman, AuD, answers our questions on the importance of monitoring hearing as a patient gets older, how hearing loss affects the brain, and the link between untreated hearing loss...
11/28/2022
Risk Management
Risk Management
11/21/2022
In this Q&A, Sara Reece, PharmD, CDCES, discusses the use of GLP-1 agonists and SGLT-2 inhibitors to improve cardiovascular and renal outcomes in patients with type 2 diabetes.
11/21/2022
mortality risk
mortality risk
11/16/2022
Lead study author Lana Mucalo, MD, discusses her team’s study examining the prevalence of opioid-related mortality in patients with sickle cell disease from 2013 to 2019. She presented her research at the...
11/16/2022
diagnostic testing
diagnostic testing
11/13/2022
In this Q&A, Gianluca Tornese, MD, PhD, discusses the diagnosis of pediatric growth hormone deficiency with the use of stimulation tests, as well as the reliability and pitfalls of this diagnostic tool...
11/13/2022
disease progression
Jan Varga, PhD
disease progression